Stock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade

Stock Track

01-09

Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.

The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.

However, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1160380170"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1160380170\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1160380170?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-09 13:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160380170","market":"hk","top_or_hot":-1,"title":"Stock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade","media":"Stock Track","content":"<p>Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.</p>\n\n<p>The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.</p>\n\n<p>However, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Everest Medicines Plummets 5.04% on Controlling Shareholder's Block Trade\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-01-09 13:04</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.</p>\n\n<p>The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.</p>\n\n<p>However, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"雲頂新耀-B","start_time":0,"source_url":"","article_id":"1160380170","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160380170","pubTimestamp":1736399074,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Everest Medicines , a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.The significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀-B"},"translate_title":"股票赛道珠峰医药因控股股东大宗交易暴跌5.04%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"Everest Medicines (HKG:1952), a biopharmaceutical company focused on developing and commercializing innovative therapies, saw its stock plummet by 5.04% during the Thursday trading session.\nThe significant drop in the company's share price can be attributed to a block trade conducted by its controlling shareholder, CBC Group. According to a filing with the Hong Kong bourse, CBC Group sold 17.1 million shares of Everest Medicines to international investors on Wednesday, leading to unusual price and trading volume fluctuations.\nHowever, the company has clarified that this event does not impact its operations or financial position. CBC Group still retains over 34% ownership in Everest Medicines, and the executives did not participate in the share sale.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}